Get started
Author

Evgeny Klyuchnikov

Observed names: E Klyuchnikov, E. Klyuchnikov, Klyuchnikov, Evgeny
ORCID: 0000-0001-9407-1413
Observed ORCID: 0000-0001-9407-1413
OpenAlex ID: A5082945503
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
2015 · Abraham S. Kanate, Alberto Mussetti, et al. · Blood · 273
PDF
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
2012 · Ulrike Bacher, Evgeny Klyuchnikov, et al. · Blood · 138
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
2019 · Donal McLornan, Richard Szydlo, et al. · Transplantation and Cellular Therapy · 102
PDF
JAK2-V617F–triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation
2009 · Nicolaus Kröger, Haefaa Alchalby, et al. · Blood · 97
CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies
2013 · Evgeny Klyuchnikov, Jean El-Cheikh, et al. · Transplantation and Cellular Therapy · 96
PDF
Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma
2012 · Nicolaus Kröger, Anita Badbaran, et al. · Transplantation and Cellular Therapy · 88
PDF
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma
2009 · Nicolaus Kröger, Anita Badbaran, et al. · Experimental Hematology · 86
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
2021 · Michael Scordo, Trent P. Wang, et al. · JAMA Oncology · 85
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors
2015 · Evgeny Klyuchnikov, Ulrike Bacher, et al. · Transplantation and Cellular Therapy · 62
PDF
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced‐intensity allografting
2012 · Evgeny Klyuchnikov, Ernst Holler, et al. · British Journal of Haematology · 59
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
2012 · N Kröger, T Zabelina, et al. · Bone Marrow Transplantation · 49
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma
2015 · E Klyuchnikov, U Bacher, et al. · Bone Marrow Transplantation · 42
Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?
2013 · E Klyuchnikov, U Bacher, et al. · Bone Marrow Transplantation · 42
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
2018 · Donal P. McLornan, Richard Szydlo, et al. · British Journal of Haematology · 38
PDF
Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
2013 · C Wolschke, T Zabelina, et al. · Bone Marrow Transplantation · 37
Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML)
2009 · Evgeny Klyuchnikov, Nicolaus Kröger, et al. · Transplantation and Cellular Therapy · 37
PDF
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia
2010 · Bettina Wiedemann, Evgeny Klyuchnikov, et al. · Experimental Hematology · 33
Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients
2023 · Nico Gagelmann, Francis A. Ayuk, et al. · Haematologica · 32
PDF
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
2011 · N Kröger, T Zabelina, et al. · Leukemia · 31
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia—a report from the German Registry covering the period from 1998 to 2004
2009 · Ulrike Bacher, Evgeny Klyuchnikov, et al. · Annals of Hematology · 28
TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
2021 · Nico Gagelmann, Christine Wolschke, et al. · Frontiers in Immunology · 27
PDF
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
2018 · Maximilian Gröger, Nico Gagelmann, et al. · Transplantation and Cellular Therapy · 27
Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia
2021 · Evgeny Klyuchnikov, Anita Badbaran, et al. · Transplantation and Cellular Therapy · 26
Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia
2010 · Evgeny Klyuchnikov, Svetlana Asenova, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 26
Challenges for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
2011 · Anthony Oyekunle, Evgeny Klyuchnikov, et al. · Acta Haematologica · 25
Works count: 111
Citation count: 2,045
H-index: 25
I10-index: 45
Year
Topic
Type